NuVasive reached an agreement with the U.S. Department of Justice related to the subpoena for from the Office of the Inspector General of the Department of Health and Human Services issued in 2013.
Here are five key notes:
1. NuVasive will pay $13.8 million, including fees, to the United States to resolve the matter.
2. NuVasive does not anticipate entering into a corporate integrity agreement with the OIG related to the settlement.
3. It could take months to finalize the written statement agreement.
4. Since being issued the subpoena, the company has cooperated fully with the inquiry and responded to government concerns.
5. The resolution avoids the time and expenses of a possibly lengthy litigation process.